HealthCare Market Analysis

The global  electroceuticals/bioelectric medicine market   is expected to reach USD 35.5 billion by 2025, according to a new report by Grand View Research, Inc. Rising geriatric population is the major factor that is expected to propel growth during the forecast period. Aging population is prone to various diseases such as cardiac arrhythmias, Parkinson's disease, Alzheimer's disease, epilepsy, and depression. There are various advanced electroceuticals including implantable cardioverter defibrillators, cochlear implants, cardiac pacemakers, and spinal cord stimulators, which can be used for the treatment of these conditions.  Increasing investment in the development of advanced bioelectric medicine is another major factor supporting the growth of the electroceuticals market. For instance, in FY 2016, Medtronic, a leading bioelectric medicine manufacturer, invested around USD 2,224 million in R&D for development of advanced products. Technological advancements in thes

Global  Antidiabetics  Market is expected to reach USD 84.13 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth. Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness. Browse full research report on

Global  anti-snoring devices and snoring surgery market  is expected to reach USD 1.84 billion by 2024, according to a new report by Grand View Research, Inc. The anti-snoring devices and snoring surgery market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing awareness levels about the ill effects of snoring, rising elderly and obese population, the presence of an unexploited consumer base, and the increasing consumption of alcohol and cigarettes. However, factors such as the cost prohibitive nature of the products, limited efficacy of the presently available treatments, and the presence of an unpropitious reimbursement scenario are likely to hinder the growth of the market. The market is segmented into anti-snoring devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabiliz

The  anesthesia monitoring devices market  is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications. The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period. Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, m

The global  revenue cycle management (rcm) market   is expected to reach USD 65.2 billion by 2025, according to a new report by Grand View Research, Inc. The healthcare system is witnessing a paradigm shift primarily due to the changing dynamics of the business models. These changing dynamics of the hospital industry in developed regions is expected to involve centralization and digitalization of the back-end processes, thereby demanding the implementation of revenue cycle management, which is anticipated to positively affect the market growth. The healthcare industry is extremely vast and its centralization will help in synchronizing the entire work process along with providing economic benefits. Almost all industries aim to achieve lean management and six-sigma incorporation in their work culture to optimize resource usage and increase efficiency. Furthermore, development of value-added services, i.e., integration of RCM system with other healthcare IT solutions such as

The global  structural heart devices market  is expected to reach USD 9.1 billion by 2025, based on a new report by Grand View Research, Inc. The market is expected to witness an exponential growth over the next 8 years due to the rapid increase in cardiovascular conditions and increasing power of healthcare expenditure. The defects are mostly present at birth, thereby directly affecting the under-5 mortality rate of a country. Therefore, rigorous actions are being undertaken by various government bodies across the globe to increase access to treatment. The Centers for Disease Control and Prevention have a public action plan to efficient management of cardiac conditions. In addition, other organizations are working on improving the scenario for structural heart diseases treatment. For instance, in November 2016, the Cardiovascular Research Foundation (CRF) announced a launch of a journal focusing on diagnosis and treatment of structural heart defects. It was titled  Structura

The global  therapeutic bed market  is expected to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base coupled with the rising cases of obesity, chronic conditions, and viral infections are expected to boost market growth over the forecast period.  As per the U.S. Bureau of Labor Statistics, the rank of home health aides and personal care aides is expected to increase to 13.0 million in 2020 (a 70.0% increase from 2010), thereby increasing the demand for home care. This growth is expected to increase the sale of household therapeutic beds and propel growth over the forecast period. Considering that the treatment costs at home are lower than other settings, many patients are now preferring home healthcare, thus, ultimately increasing the demand for therapeutic beds in these facilities.  Another macro factor promoting the Therapeutic Bed Market is the increase in the volume of healthcare settings across the

The global  mycoplasma testing market  is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market. Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent. Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research

The global  electronic data capture (EDC) systems market  is expected to reach USD 1.16 billion by 2025, according to a new study by Grand View Research, Inc. The rising demand for software solutions in clinical trials, increasing R&D expenditure by companies in healthcare, supportive government initiatives to boost trials, and increasing number of potential customers implementing Electronic Data Capture (EDC) systems are some of the key factors contributing to the market growth. The market is growing rapidly owing to the technological advancements in eClinical solutions and this is anticipated to serve this industry with future growth opportunities. Furthermore, increasing awareness pertaining to EDC solutions is predicted to fuel the demand in near future. Moreover, government organizations such as Agency for Healthcare Research and Quality and The Office of National Coordinator for Health Information Technology are promoting the adoption of electronic systems for data mana

The global  coronary artery bypass graft (CABG) market  is expected to reach USD 127.6 million by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to increasing prevalence of Cardiovascular Diseases (CVDs) such as Coronary Artery Disease (CAD) or Coronary Heart Disease (CHD) coupled with rising geriatric population across the globe. Favorable reimbursement policies, such as the U.S. Medicare (federal health insurance program) system, Medicaid, and National Health Insurance (NHI) have been a prime growth factor for the CABG market. Medical device companies provide new product platforms, which are covered under reimbursement programs that benefit the patients. Reimbursement services provided by Medicare and other insurers to physicians and hospitals is expected to fuel the demand for the adoption of CABG devices such as catheters, cannulae, retractors, positioners & stabilizers, sucti

The global  stem cells market  size is expected to reach USD 170.15 billion by 2020, according to a new report by Grand View Research, Inc. The market is expected to grow because of increasing research and development to develop therapeutic solution for chronic diseases and the huge funding by the government for drug discovery and development to serve the large unmet medical needs. The WHO statistics on Cancer (2012) concluded that it is the leading cause for global mortality and morbidity, with around 14 million new cancer cases and 8.2 million cancer related deaths which is estimated to reach 22 million in next two decades. Stem cells in combination with gene therapy along with DNA repair is anticipated to be used to treat many intractable diseases and is classified under orphan drugs. The California’s Stem Cell Agency has spent around USD 1.4 billion for stem cell research and still has USD 872 million to provide for the same. In addition to this, in 2013 the National Inst

The global  surgical equipment market  is anticipated to reach a value of USD 20.3 billion by 2025, according to a new report by Grand View Research, Inc. The rapidly escalating number of minimally invasive surgical procedures throughout the world is expected to support market growth. Chronic diseases are one of the major leading causes of surgeries at a global level. Increasing prevalence of chronic diseases, such as neurological and cardiovascular disorders, is affecting the society to a great extent. As a result of which, the number of surgeries is increasing. This is mainly due to the fact that surgery is the primary treatment for people suffering from such disorders. In addition, minimally invasive surgeries are also trending as treatment for heart diseases. Road and other accidents are also expected to drive the surgical instruments market over the forecast period. This is due to the fact that accidents might lead to severe injuries. As a result of which, wound closure